Across TCGA pan-cancer cohorts, PGAM5P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PGAM5P1’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where PGAM5P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PGAM5P1 is over-expressed in tumor.
KIRC and LUAD are the cancer types where PGAM5P1 tumor–normal differential expression is most reproducible.